New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - valganciclovir hydrochloride 496.3mg equivalent to 450 mg valganciclovir - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to 450 mg valganciclovir excipient: crospovidone microcrystalline cellulose opadry pink 15b24005 povidone stearic acid - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. valcyte is indicated for the prevention of cmv disease in solid organ transplant patients at risk.

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - valganciclovir - tablet, film coated - 450 mg - valganciclovir 450 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg excipient: crospovidone microcrystalline cellulose opadry brown 15b565009 purified water stearic acid - for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. for the prevention of cmv disease in solid organ transplant patients at risk.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - valganciclovir hydrochloride - oral tablet - 450mg

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - valganciclovir, quantity: 450 mg (equivalent: valganciclovir, qty 496.3 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; crospovidone; stearic acid; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400 - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prophylaxis of cmv disease in adult and paediatric solid organ transplantation (sot) patients who are at risk.